medigraphic.com
SPANISH

Revista ADM Órgano Oficial de la Asociación Dental Mexicana

ISSN 0001-0944 (Print)
Órgano Oficial de la Asociación Dental Mexicana
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
    • Send manuscript
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2009, Number 3

<< Back Next >>

Rev ADM 2009; 66 (3)

Dental treatment with sedation in preschool

Bravo MCA, Flores ZRM, Barradas VJR
Full text How to cite this article

Language: Spanish
References: 23
Page: 34-39
PDF size: 338.62 Kb.


Key words:

ansiolisis, pediatric sedation, midazolam.

ABSTRACT

Introduction: Anxiety is an answer to the stress that predisposes anguish and it is manifested with multiple psychological, physiologic and behavioral reactions that can be controlled depending on the age and each person’s character.
In preschool age whose capacity of understanding is in development, the exhibition to a dental treatment can cause stress levels that generate anxiety, anguish, important psycho physiological symptoms and uncontrollable behaviors.
Diverse previous studies have described the benefit of sedation in patients that present manifestations of anxiety before being treated medical or odontogycal.
The objective of this study is to demonstrate the benefits of the sedation with oral midazolam in preschool that require dental treatments.
Material and method: A controlled clinical study was designed, prospective, traverse, random simple of cohorts, with a sample of 100 children of 2 to 5 years of age divided in 2 groups that required dental treatment.
They were discarded patient treatment with antiseizures or neuroleptyc drugs and patient without anxiety, as well as those that didn’t sign the informed authorization.
The group I you handling low sedation with 400 mcg of oral midazolam; the group II were the control, being used several subjection forms. Both they were assisted with technical traditional for each lesion, included local anesthesia.
Anxiety was evaluated, sedation levels (latency, effective time and recovery), secondary effects, amnesia and vital signs during the treatment. The statistical evaluation was made with the program Epi Info 2002.
Results: The age stocking was of 3.5 years with prevalence of the masculine sex (56%), the assisted lesions were baby bottle cavity, decay of diverse grade and dental fractures, being made in total 154 obturations,157 crowns, 35 pulpotomyes and 26 extractions. In the soothe children , the stockings were: time of latency 28 min, sedation 65 min and recovery 15 min. The sedation effectiveness was excellent in 93% and 92% of total amnesia.
The success in ansiolisis and amnesia was successful with value of Chi2 with p ‹0.00001 and exact test of Fisher p ‹0.0001.
The group II showed important anxiety with alteration of signs vital and difficult handling in 95% of the cases, while the group I had normality of signs and 2 cases only presented drowsiness for 25 minutes after the time of recovery.
Discussion: The anxiety, anguishes and behavioral stress associated to medical or dental procedures they are frequent in almost all the children, being the preschool the most sensitive to have bigger levels and control loss, when not understanding its lesion and the required treatment, what hinders its appropriate attention, even using technical of subjection that for themselves, they are aggressors.
This study shows the benefits of using a technique of sure sedation, with what the therapeutic maneuvers and possibility of wide treatments are facilitated with a time average of sedation of 1 hr, minimizing the stress in the revision consultations, being a simple, effective technique and of low cost.


REFERENCES

  1. Hollister LE, Muller Oerlinghausen B, Rickels K y cols: Clinical uses of benzodiazepines. J Clin Psychopharmacol 1993; 13 (6 Suppl 1): 1S-160S

  2. Salas AM, Gavaldón PO, Mayoral MJL, Amayra CI: Evaluación de la ansiedad y dolor asociados a procedimientos médicos dolorosos en oncología pediátrica. An Esp Pediat 2002;57:34-44

  3. Tesar GE, Rosenbaum JF, Pollack MH, y cols: Double-blind, placebo-controlled comparison of clonacepan and alprazolam for panic disorder. J Clin Psychiatry 1991; 52 (2): 69-76

  4. Moroz G, Rosenbaum JF: Efficacy, safety and gradual discontinuation of clonacepam in panic disorder; a placebocontrolled, multicenter study used optimized dosages. J Clin Psychiatry 1999; 60 (9): 604-612

  5. Davison JR: Use of benzodiazepines in panic disorder. J Clin Psychiatry 1997; 58 (Suppl 2): 26-28

  6. Herman JB, Rosenbaum JF, Brotman AW: The alprazolam to clonacepam switch for the treatment of panic disorder. J Clin Psychopharmacol 1987; 7 (3): 175-178

  7. El niño vulnerable. http://www.zonapediatrica.com/patologías/ninovul.htm 2002

  8. Ansiedad y dolor en la odontología. Enfoque psico fisio patológico (editorial). Rev Ass Paulista Cir Dent 1995;49 (4):285-290)

  9. Taboada JAM, Ezpeleta AL, De la Osa CN: Trastornos por ansiedad en la infancia y adolescencia: actors de riesgo. Ansiedad y Estrés 1998;4 (1):1-16

  10. Krafft TC, Kramer N, Kunzelmann KH, Hickel R: Experience with midazolam as sedative in dental treatment of uncooperative children. J Dent Child 1993: 60:295-299

  11. Gallardo F, Cornejo O, Barie R: Oral midazolam as premedication for apprehensive child before dental treatment. J Clin Pediatr Dent 1994;18 (2): 123-127

  12. Hartgraves PM, Prinosch RE: An evaluation of oral and nasal midazolam fr pediatric dental sedation. J Dent Child 1994;61 (3): 175-181

  13. Martínez-Soberanis MI, Martínez RJ: Sedación en odontopediatría. Comparación del midazolam vía intranasal con el diazepam vía oral. Rev ADM 1995;52 (5): 261-265

  14. Karl HW, Rosenberger JL, Laranch MG, Ruffle JM: Transmucosal administration of midazolam for premedication of pediatric patients. Anesthesiology 1994; 78 (5): 880-870

  15. Kupietzky A, Houpt MI: Midazolam: A review of its use for conscious sedation of children. Pediatric Dentistry 1993; 15 (4): 237-241

  16. Fukuta O y cols: The sedative effect of intranasal midazolam administration in the dental treatment of patients with mental disabilities. Part1. The effect of a 0. 2 mg/kg dose. J Clinical Pediatr Dent 1993; 17 (4): 231-237

  17. Bravo MC, García GJ, Flores BRM: Midazolam oral en cirugía pediátrica. Arch Invest Ped Mex 2000; 3 (10): 333-337

  18. Zhang H, Zhang J, Streisand J: Oral mucosal drug delivery: Clinical pharmacokinetics and therapeutic applications. Clin Pharma 2002;41 (9): 661-680

  19. Fernández BR: Evaluación de las características psicopatológicas. http://www.psicoactiva.com/estudio/psicodiag b.doc 1998

  20. Vaz Serra A, Figueira ML, Bessa Peizoto A y cols: Mexazolam y alprazolam en el tratamiento de la ansiedad generalizada, ensayo doble ciego. Clin Drug Invest 2001; 21 (4): 257-263

  21. Molina Moreno A: Instrumentos de la evaluación clínica en niños y adolescentes. Rev Psiquiatr Psicol. Niño y Adolesc 2001; 2 (1): 23-40

  22. Lawrence HF, Negus JB, Withe PG: Oral midazolam preanesthesic medication in pediatric out patients. Anesthesiology 1990; 73: 831-834

  23. Vega Franco L: Endulcemos el dolor de los niños: puede ser una alternativa para atenuar su dolor. Rev Mex Pediatr 2000; 67 (4): 152-153




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev ADM. 2009;66